// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Efficacy of a 3-Month Wearable-enabled Physical Activity Counselling Program for People with Knee Osteoarthritis

Hui Xie - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Efficacy of a Counselling Program to Promote Physical Activity in People with Inflammatory Arthritis

Hui Xie - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Efficacy of Leflunomide for Treatment of Vasculitis

NOURA MUSTAPHA - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Glucocorticoid

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor, Fenebrutinib (GDC-0853), in Moderate to Severe Systemic Lupus Erythematosus: Results of a Phase 2 Randomized Controlled Trial

Richard Furie - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Fenebrutinib

Emotional and Social Determinants of Health Increase Office Communication for Patients with Rheumatoid Arthritis

Michael Wu - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

Enhanced Performance of the ASAS Classification Criteria by Deletion of Non-Discriminatory Clinical Items: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort

Raj Carmona - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Axial spondyloarthritis

N/A

Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort

Daniela Dominguez - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Evaluating an Illustrated Storybook for Children with Juvenile Idiopathic Arthritis

Dennis Newhook - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Evidence for Substantial Immune Activation in Asymptomatic ANA Positive Individuals

Dennisse Bonilla - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Exploring Possible Predictors of Physical Activity in Knee Replacement Patients

Brandy Tanenbaum - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Osteoarthritis

N/A

Extensive Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results from the FRAME Clinical Trial

Roland Chapurlat - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Tetracycline

Factors Implicated in the Development of Early Osteonecrosis in Systemic Lupus Erythematosus

Dafna Gladman - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Farber Disease (Acid Ceramidase Deficiency): The First Natural History Study of This Rare Disease Involving Symptoms Which Can Mimic JIA

Erik Sundberg - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Farber lipogranulomatosis

N/A

Features of Pneumocystis Jirovecii Pneumonia in Juvenile Idiopathic Inflammatory Myopathy

Jessica Neely - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Pneumocystis Jiroveci Pneumonia

N/A

Frequently Encountered Artifacts in Novel Application of Dual-Energy CT to Vascular Imaging: A Pilot Study

Sterling Eide - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

N/A

Genetics of Longitudinal Kidney Function in Children and Adults with Systemic Lupus Erythematosus

Declan Webber - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Stribild

Global Management of Patients with Knee Osteoarthritis Begins with Quality of Life Assessment: A Systematic Review

Marianna Vitaloni - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Glucocorticosteroid Usage and Major Organ Damage in Patients with Systemic Lupus Erythematosus – Meta-analyses of Observational Studies Published Between 1979 and 2018

Mike W.L.- Cheung - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Prednisone

Guidelines on Prescribing and Monitoring Antimalarials in Rheumatic Diseases: A Systematic Review

Janet Pope - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Guselkumab, an Anti-interleukin-23p19 Monoclonal Antibody, in Biologic-naïve Patients with Active Psoriatic Arthritis: Week 24 Results of the Phase 3, Randomized, Double-blind, Placebo-controlled Study

Proton Rahman - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Interleukin

Copyright © 2026. QuantiNova All rights reserved